Stock BIOSGN BIOSERGEN AB
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Biosergen AB

Equities

BIOSGN

SE0016013460

Delayed Nasdaq Stockholm
Other stock markets
 10:03:26 13/06/2024 BST 		5-day change 1st Jan Change
0.308 SEK -0.32% Intraday chart for Biosergen AB -5.23% -65.00%
06-11 Biosergen AB Receives the Final Permission Required to Test Lead Candidate BSG005 in Patients with Invasive Fungal Infection CI
05-31 Biosergen AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOSERGEN AB
Bio Therapeutic Drugs
-0.32%-5.23%-65.00%-71.74% - 4.27M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BIOSGN Stock
  4. Charts Biosergen AB
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW